Smith Jason Drew's Form 4 filing
UroGen Pharma Ltd. (URGN) · filed Feb 4, 2025
- Accession no.
- 0001437749-25-002685
- Filed
- Feb 4, 2025
- Trade date
- Jan 31, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 4 derivative transactions. Open-market sales total $82.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Jason DrewCIK 0001821479 | Officer (General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Ordinary Shares | MOption exerciseAcquired | +2,500 | –F1 | – | 27,726 | Direct | |
| Jan 31, 2025 | Ordinary Shares | SSaleDisposed | −1,258 | $11.14 | −$14,014.12 | 26,468 | Direct | |
| Jan 31, 2025 | Ordinary Shares | MOption exerciseAcquired | +6,667 | –F1 | – | 33,135 | Direct | |
| Jan 31, 2025 | Ordinary Shares | SSaleDisposed | −3,354 | $11.14 | −$37,363.56 | 29,781 | Direct | |
| Jan 31, 2025 | Ordinary Shares | MOption exerciseAcquired | +5,500 | –F1 | – | 35,281 | Direct | |
| Jan 31, 2025 | Ordinary Shares | SSaleDisposed | −2,767 | $11.14 | −$30,824.38 | 32,514 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Ordinary Shares | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 0 | Direct | |
| Jan 31, 2025 | Ordinary Shares | MOption exerciseDisposed | −6,667 | $0.00 | $0 | 6,667 | Direct | |
| Jan 31, 2025 | Ordinary Shares | MOption exerciseDisposed | −5,500 | $0.00 | $0 | 11,000 | Direct | |
| Jan 31, 2025 | Ordinary Shares | AGrant or awardAcquired | +10,000 | $0.00 | $0 | 10,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
Referenced by the price of 3 transactions in Table I.